by Biospring | Apr 26, 2022 | Astrazeneca, Biospring Partners, COVID-19, Economy, Jay Bradner, Katie Burke, Novartis, Oxford, Peter B. Henry, Return to work, Sir John Bell, Vaccines
Last December, we hosted a discussion with industry leaders on COVID-19 and Vaccines, Return-to-Work, and the Economy. We were delighted to host Dr. Jay Bradner, President of the Novartis Institutes for BioMedical Research (NIBR) and Biospring’s advisors Sir...
by Biospring | Apr 24, 2022 | Chemistry, Computer Aided Molecular Design, Drug Design, Graham Richards, Oxford, Pharma
Professor Graham Richards is Commander of the Order of the British Empire and former Head of Chemistry at the University of Oxford. He is a pioneer in the field of computational chemistry and computer-aided molecular design, particularly as it applies to the...
